Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free SVA Stock Alerts

Sernova (SVA) Competitors

Sernova logo
C$0.11 0.00 (0.00%)
As of 10:49 AM Eastern
Compare

SVA vs. HBP, SCYB, COM, NVH, and PDP

Should you buy Sernova stock or one of its competitors? Sernova's main competitors and comparable companies include Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), and Pediapharm (PDP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Sernova compare to Helix BioPharma?

Sernova (TSE:SVA) and Helix BioPharma (TSE:HBP) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

0.0% of Sernova shares are owned by institutional investors. Comparatively, 0.0% of Helix BioPharma shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Comparatively, 2.2% of Helix BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Helix BioPharma'saverage media sentiment score.

Company Overall Sentiment
Sernova Neutral
Helix BioPharma Neutral

Helix BioPharma is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
Helix BioPharmaN/AN/A-C$50.55M-C$0.04N/A

Sernova has a beta of -0.460559, suggesting that its stock price is 146% less volatile than the broader market. Comparatively, Helix BioPharma has a beta of 0.433836, suggesting that its stock price is 57% less volatile than the broader market.

Sernova's return on equity of 55.85% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Helix BioPharma N/A -21.54%-279.98%

Summary

Sernova beats Helix BioPharma on 6 of the 7 factors compared between the two stocks.

How does Sernova compare to Scythian Biosciences?

Scythian Biosciences (CVE:SCYB) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scythian BiosciencesN/AN/AN/AN/AN/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Sernova's return on equity of 55.85% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Scythian BiosciencesN/A N/A N/A
Sernova N/A 55.85%-119.26%

In the previous week, Scythian Biosciences' average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Scythian Biosciences Neutral
Sernova Neutral

Summary

Sernova beats Scythian Biosciences on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to 138267 (COM.TO)?

138267 (COM.TO) (TSE:COM) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

In the previous week, 138267 (COM.TO)'s average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
138267 (COM.TO) Neutral
Sernova Neutral

Sernova's return on equity of 55.85% beat 138267 (COM.TO)'s return on equity.

Company Net Margins Return on Equity Return on Assets
138267 (COM.TO)N/A N/A N/A
Sernova N/A 55.85%-119.26%

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Summary

Sernova beats 138267 (COM.TO) on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to Novoheart?

Novoheart (CVE:NVH) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Novoheart has higher revenue and earnings than Sernova. Novoheart is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Novoheart's average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Novoheart Neutral
Sernova Neutral

Sernova's return on equity of 55.85% beat Novoheart's return on equity.

Company Net Margins Return on Equity Return on Assets
NovoheartN/A N/A N/A
Sernova N/A 55.85%-119.26%

Summary

Novoheart and Sernova tied by winning 4 of the 8 factors compared between the two stocks.

How does Sernova compare to Pediapharm?

Pediapharm (CVE:PDP) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

Pediapharm has higher revenue and earnings than Sernova. Pediapharm is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PediapharmC$11.16M5.95-C$16.15M-C$0.07N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Pediapharm's average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
Pediapharm Neutral
Sernova Neutral

Sernova's return on equity of 55.85% beat Pediapharm's return on equity.

Company Net Margins Return on Equity Return on Assets
PediapharmN/A N/A N/A
Sernova N/A 55.85%-119.26%

Summary

Sernova beats Pediapharm on 5 of the 8 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

Export
MetricSernovaBiotechnology IndustryHealthcare SectorTSE Exchange
Market CapC$41.54MC$3.74BC$7.02BC$12.58B
Dividend Yield7.86%3.76%2.58%6.20%
P/E Ratio-2.7510.50268.7934.81
Price / SalesN/A1,237.05574.3210.02
Price / Cash6.15102.5472.2682.29
Price / Book-4.0117.7713.134.64
Net Income-C$35.70M-C$13.23MC$3.44BC$299.09M
7 Day PerformanceN/A3.88%2.07%2.10%
1 Month Performance-12.00%-0.58%-0.31%3.45%
1 Year Performance-42.11%60.87%70.62%36.17%

Sernova Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.11
flat		N/A-42.1%C$41.54MN/AN/A1,959
HBP
Helix BioPharma
N/AC$1.58
+2.6%		N/A+53.7%C$120.68MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A
NVH
Novoheart
N/AC$0.53
+1.9%		N/A+0.0%C$99.98MC$423.50KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:SVA) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The trading strategy that works BECAUSE you have a life
Tim Sykes built a trading strategy for people who can't watch charts from 9:30 to 4:00 every day. It's not ...
Tim Sykes | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
One trade you can make to move the needle today
Eric Fry has been analyzing markets since the 1980s, working as a professional portfolio manager for over a de...
InvestorPlace | Sponsoredtc pixel